Bone Loss Recruiting Phase 4 Trials for Denosumab (DB06643)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04087096Denosumab to Prevent High-Turnover Bone Loss After Bariatric SurgeryPrevention